Krishna Bharwani

Dr. Krishna Bharwani is a Researcher at Erasmus MC's Department of Anesthesiology, focusing on complex regional pain syndrome (CRPS) and ketamine-based therapies. His work bridges clinical practice and pharmacological innovation, emphasizing mechanism-based treatments over symptom management. Key areas include biomarker discovery for CRPS severity, comparative ketamine infusion protocols, and nationwide ketamine therapy utilization patterns.

Research Interests: CRPS pathophysiology, ketamine pharmacology, pain modulation mechanisms, and translational pain medicine. His studies integrate immunological markers (e.g., soluble interleukin-2 receptors) with clinical outcomes to refine therapeutic approaches.

Collaborations involve multidisciplinary teams exploring CRPS treatment protocols and pain biomarkers. Recent work includes a randomized controlled trial comparing ketamine infusion strategies and a nationwide survey analyzing ketamine use for chronic pain in Dutch healthcare settings.

Publications highlight both primary research and review articles, with contributions to Pain Medicine, Drugs, and BMC Musculoskeletal Disorders. His work emphasizes evidence-based practices and innovative drug delivery methods for refractory pain conditions.